Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. TMO Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Thermo Fisher Scientific (TMO)

Market Price (9/17/2025): $480.7 | Market Cap: $181.7 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Thermo Fisher Scientific (TMO)

Market Price (9/17/2025): $480.7
Market Cap: $181.7 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services

Investment Highlights

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 14%, CFO LTM is 7.6 Bil, FCF LTM is 6.2 Bil		 Weak multi-year price returns
2Y Excs Rtn is -53%, 3Y Excs Rtn is -77%		 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 22x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 24x, P/EPrice/Earnings or Price/(Net Income) is 28x
1 Low stock price volatility
Vol 12M is 31%		  Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.3%
0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 14%, CFO LTM is 7.6 Bil, FCF LTM is 6.2 Bil
1 Low stock price volatility
Vol 12M is 31%
2 Weak multi-year price returns
2Y Excs Rtn is -53%, 3Y Excs Rtn is -77%
3 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 22x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 24x, P/EPrice/Earnings or Price/(Net Income) is 28x
4 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.3%

Market Valuation

 9/17/252024202320222021
Share Price CYE$480.70$518.79$527.88$546.21$660.35
Market Cap CYE ($ Bil)181.7198.2203.8214.1260.2
Total Debt ($ Bil)35.231.334.934.534.9
Total Cash ($ Bil)6.45.68.18.54.5
Enterprise Value ($ Bil)210.5229.5238.7248.6295.1
Valuation Ratios     
P/S TTM4.24.64.84.86.7
P/EBIT TTM21.623.626.725.228.0
P/E TTM27.631.434.231.134.0
Sector Ratios     
P/S TTM (Sector)3.73.64.14.57.3
P/EBIT TTM (Sector)-1.6-1.3-1.4-1.3-2.9
P/E TTM (Sector)-1.8-1.5-1.5-1.3-2.9
 9/17/2520242023
Share Price CYE$480.70$518.79$527.88
Market Cap CYE ($ Bil)181.7198.2203.8
Total Debt ($ Bil)35.231.334.9
Total Cash ($ Bil)6.45.68.1
Enterprise Value ($ Bil)210.5229.5238.7
Valuation Ratios   
P/S TTM4.24.64.8
P/EBIT TTM21.623.626.7
P/E TTM27.631.434.2
Sector Ratios   
P/S TTM (Sector)3.73.64.1
P/EBIT TTM (Sector)-1.6-1.3-1.4
P/E TTM (Sector)-1.8-1.5-1.5

Market Cap Chart

Business Description

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
TMO Return44%44%-17%-3%-2%-7%50%
Peers Return37%38%-23%33%4%21%143%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: TXN, MU, AMAT, ADI, TMO. See TMO Returns vs. Peers.
[3] 2025 data is for the year up to 9/16/2025 (YTD)

Better Bets than Thermo Fisher Scientific (TMO)

 TMOBetter Performance than TMO
MetricValueIndustry (Life Sciences Tools & Services)
Rev Chg LTM2.0%A (4.5%), IQV (3.6%), MTD (3.1%), NTRA (44.4%), WAT (5.9%)
Rev Chg 3Y Avg0.3%A (0.8%), IQV (3.6%), NTRA (39.7%), WAT (1.7%), MEDP (20.4%)
Op Mgn LTM18.2%DHR (18.4%), A (21.3%), MTD (28.4%), WAT (27.7%), ILMN (19.2%)
CFO/Rev LTM17.5%DHR (25.7%), A (22.0%), MTD (24.6%), WAT (24.5%), ILMN (26.9%)
FCF/Rev LTM14.3%DHR (20.2%), A (16.0%), MTD (21.9%), WAT (20.3%), ILMN (23.9%)
Total Yield3.6%A (4.2%), IQV (3.9%), WAT (3.7%), ILMN (7.9%), ICLR (5.8%)
 TMOBetter Performance than TMO
MetricValueAll Other Sectors
Rev Chg LTM2.0%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg0.3%NVDA (92.0%), MSFT (12.5%), AAPL (1.8%), GOOGL (10.2%), AMZN (11.3%)
Op Mgn LTM18.2%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), META (42.9%)
CFO/Rev LTM17.5%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM14.3%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield3.6%GOOGL (4.1%), META (3.6%), BRK-B (5.9%), JPM (6.6%), V (3.8%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Thermo Fisher Scientific Earnings Notes  
2TMO Jumps 15% in a Month, But Does GOOGL Offer Better Fundamentals?Counter-Intuitive Comparisons 
3After TMO's 15% Climb in a Month, JNJ Looks Like the Stronger Long-Term PlayCounter-Intuitive Comparisons 
4Day 7 of Gains Streak for Thermo Fisher Scientific Stock with 8.9% Return (vs. -5.8% YTD) [8/15/2025]Notification 
5How Does TMO Stack Up Against Its Peers?Peer Comparison 
6Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From GOOGL, TMUS   
7Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From MRK, GILD   
8Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From IQV   
9NTRA Looks Stronger Than TMO With 68% Return PotentialActionable 
10Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From IQV Actionable 
11ARTICLES  
12TMO Stock Up 8.9% after 7-Day Win Streak August 16th, 2025
13EXAS Looks Stronger Than TMO With 50% Return Potential July 31st, 2025
14Better Bet Than Thermo Fisher Scientific Stock: Pay Less To Get More From IQV July 30th, 2025
15TMO Stock Up 20% after 5-Day Win Streak July 29th, 2025
16How Does TMO Stock Compare With Its Peers Right Now? July 26th, 2025
Title
0DASHBOARDS
1TMO Stock Up 8.9% after 7-Day Win Streak
2EXAS Looks Stronger Than TMO With 50% Return Potential
3Better Bet Than Thermo Fisher Scientific Stock: Pay Less To Get More From IQV
4TMO Stock Up 20% after 5-Day Win Streak
5How Does TMO Stock Compare With Its Peers Right Now?
6ARTICLES
7Thermo Fisher Scientific Earnings Notes
8TMO Jumps 15% in a Month, But Does GOOGL Offer Better Fundamentals?
9After TMO's 15% Climb in a Month, JNJ Looks Like the Stronger Long-Term Play
10Day 7 of Gains Streak for Thermo Fisher Scientific Stock with 8.9% Return (vs. -5.8% YTD) [8/15/2025]
11How Does TMO Stack Up Against Its Peers?
12Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From GOOGL, TMUS 
13Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From MRK, GILD 
14Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From IQV 
15NTRA Looks Stronger Than TMO With 68% Return Potential
16Better Bet Than TMO Stock: Pay Less Than Thermo Fisher Scientific To Get More From IQV 

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1BDSXBiodesix1313.2%-78.6%
2CLSDClearside Biomedical954.0%-74.9%
3SDOTSadot624.1%-79.4%
4WLDSWearable Devices498.0%-30.0%
5CHEKCheck-Cap285.6%154.6%
6ATCHAtlasClear275.9%-91.0%
7HSDTHelius Medical Technologies262.5%-95.6%
8OPIOffice Properties Income Trust261.7%-13.4%
9FGIFGI Industries156.8%145.2%
10AIREReAlpha Tech154.0%-56.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1NAKAKindly MD-81.4% 
2ATYRaTyr Pharma-79.7%-70.2%
3LGCLLucas GC-73.6%-77.1%
4EPSMEpsium Enterprise-70.1% 
5BNGOBionano Genomics-59.4%-89.7%
6FAASDigiAsia-58.5%-87.2%
7QMMMQMMM-57.5%6775.0%
8VCIGVCI Global-56.9%-99.1%
9YYGHYY-56.6%-78.5%
10XAGELongevity Health-55.5%-86.1%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11963.5%11963.5%
2GIBOGIBO9734.4% 
3CHSNChanson International7565.0%-99.3%
4LNZALanzaTech Global7287.5%-86.0%
5QMMMQMMM3031.7%6775.0%
6OESXOrion Energy Systems1497.9%22.9%
7CURXCuranex Pharmaceuticals1401.6%1401.6%
8ENTOEntero Therapeutics565.6%117.6%
9PTNMPitanium553.2% 
10WLDSWearable Devices449.5%-30.0%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-92.2%-95.0%
2STFSStar Fashion Culture-92.2%-97.8%
3ELPWElong Power-91.6%-76.7%
4NXTTNext Technology-89.6%-95.1%
5NAKAKindly MD-89.0% 
6BINIBollinger Innovations-88.9%-100.0%
7JEM707 Cayman-88.4%-98.2%
8YAASYouxin Technology-82.5%-98.3%
9NEONNeonode-82.0%-50.2%
10NVNOenVVeno Medical-81.5%-69.8%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1BDSXBiodesix1313.2%-78.6%
2CLSDClearside Biomedical954.0%-74.9%
3SDOTSadot624.1%-79.4%
4WLDSWearable Devices498.0%-30.0%
5CHEKCheck-Cap285.6%154.6%
6ATCHAtlasClear275.9%-91.0%
7HSDTHelius Medical Technologies262.5%-95.6%
8OPIOffice Properties Income Trust261.7%-13.4%
9FGIFGI Industries156.8%145.2%
10AIREReAlpha Tech154.0%-56.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1NAKAKindly MD-81.4% 
2ATYRaTyr Pharma-79.7%-70.2%
3LGCLLucas GC-73.6%-77.1%
4EPSMEpsium Enterprise-70.1% 
5BNGOBionano Genomics-59.4%-89.7%
6FAASDigiAsia-58.5%-87.2%
7QMMMQMMM-57.5%6775.0%
8VCIGVCI Global-56.9%-99.1%
9YYGHYY-56.6%-78.5%
10XAGELongevity Health-55.5%-86.1%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Thermo Fisher Scientific

Financials

TMOTXNMUAMATADIMedian
NameThermo F.Texas In.Micron T.Applied .Analog D. 
Mkt Price480.74177.63158.82173.54244.10177.63
Mkt Cap181.7161.3177.6138.5120.7161.3
Rev LTM43,21116,67533,81328,61310,38728,613
Op Inc LTM7,8605,8187,5808,6232,6307,580
FCF LTM6,1701,5031,8815,8233,6783,678
FCF 3Y Avg6,6622,060-1,4126,4573,4393,439
CFO LTM7,5786,43915,2007,7054,1627,578
CFO 3Y Avg8,2066,7528,5467,7884,3107,788

Growth & Margins

TMOTXNMUAMATADIMedian
NameThermo F.Texas In.Micron T.Applied .Analog D. 
Rev Chg LTM2.0%3.6%58.2%6.6%7.1%6.6%
Rev Chg 3Y Avg0.3%-4.9%10.6%4.4%-0.6%0.3%
Rev Chg Q3.0%16.4%36.6%7.7%24.6%16.4%
QoQ Delta Rev Chg LTM0.7%3.9%7.9%1.9%5.8%3.9%
Op Mgn LTM18.2%34.9%22.4%30.1%25.3%25.3%
Op Mgn 3Y Avg17.4%39.5%0.3%29.4%27.5%27.5%
QoQ Delta Op Mgn LTM-0.1%0.6%2.8%0.5%1.8%0.6%
CFO/Rev LTM17.5%38.6%45.0%26.9%40.1%38.6%
CFO/Rev 3Y Avg19.1%39.3%32.7%28.5%39.5%32.7%
FCF/Rev LTM14.3%9.0%5.6%20.4%35.4%14.3%
FCF/Rev 3Y Avg15.5%11.7%-9.0%23.7%31.5%15.5%

Valuation

TMOTXNMUAMATADIMedian
NameThermo F.Texas In.Micron T.Applied .Analog D. 
Mkt Cap181.7161.3177.6138.5120.7161.3
P/S4.29.75.34.811.65.3
P/EBIT21.726.122.115.145.522.1
P/E27.632.028.520.361.628.5
P/CFO24.025.011.718.029.024.0
Total Yield3.6%6.2%3.8%5.9%3.2%3.8%
Dividend Yield0.0%3.0%0.3%1.0%1.6%1.0%
FCF Yield 3Y Avg3.6%1.2%-2.1%4.4%3.2%3.2%
D/E0.20.10.10.00.10.1
Net D/E0.20.10.0-0.00.00.0

Returns

TMOTXNMUAMATADIMedian
NameThermo F.Texas In.Micron T.Applied .Analog D. 
1M Rtn-1.6%-8.7%31.4%7.3%5.8%5.8%
3M Rtn23.3%-9.5%32.1%-0.0%7.7%7.7%
6M Rtn-7.6%0.6%56.5%13.7%17.7%13.7%
12M Rtn-21.4%-7.8%83.0%-6.5%11.2%-6.5%
3Y Rtn-10.4%17.6%205.9%100.7%72.4%72.4%
1M Excs Rtn-4.0%-11.1%29.0%4.9%3.4%3.4%
3M Excs Rtn9.3%-19.7%23.1%-10.9%-3.8%-3.8%
6M Excs Rtn-23.7%-16.2%38.0%-4.1%-0.1%-4.1%
12M Excs Rtn-39.5%-24.7%64.9%-22.4%-6.0%-22.4%
3Y Excs Rtn-77.2%-48.6%119.0%22.4%4.5%4.5%

Comparison Analyses

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/28/20253/29/202512/31/20249/30/20246/29/20243/30/202412/31/20239/30/20237/1/20234/1/202312/31/202210/1/2022
Filing Date8/1/20255/2/20252/20/202511/1/20248/2/20245/3/20242/22/202411/3/20238/4/20235/5/20232/23/202311/4/2022
Key Financials Quarterly            
Total Revenue10,85410,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,677
Ebitda2,7992,6283,0002,8372,9102,7882,9692,9772,6112,5222,8942,612
Operating Income1,9161,8152,2451,8841,8971,6911,9341,9481,7611,6751,9161,743
Net Income1,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,495
EPS4.283.994.794.264.053.474.224.443.533.344.033.82
Key Financials TTM            
Total Revenue TTM43,21142,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,167
Ebitda TTM11,26411,37511,53511,50411,64411,34511,07911,00410,63910,92911,94211,754
Operating Income TTM7,8607,8417,7177,4067,4707,3347,3187,3007,0957,3598,5079,175
Net Income TTM6,5846,5156,3366,1366,2216,0345,9955,9415,7216,0246,9507,032
Growth Rates Quarterly            
Total Revenue Growth3.0%0.2%4.7%0.2%-1.4%-3.4%-4.9%-1.0%-2.6%-9.4%7.0%14.4%
EBITDA Growth-3.8%-5.7%1.0%-4.7%11.5%10.5%2.6%14.0%-10.0%-28.7%6.9%-10.9%
Operating Income Growth1.0%7.3%16.1%-3.3%7.7%1.0%0.9%11.8%-13.0%-40.7%-25.9%-24.1%
Net Income Growth4.5%13.5%12.3%-5.0%13.7%3.0%3.4%14.7%-18.2%-41.8%-4.9%-21.4%
Margins Quarterly            
EBITDA Margin25.8%25.4%26.3%26.8%27.6%27.0%27.3%28.2%24.4%23.5%25.3%24.5%
Operating Income Margin17.7%17.5%19.7%17.8%18.0%16.3%17.8%18.4%16.5%15.6%16.7%16.3%
Net Income Margin14.9%14.5%16.1%15.4%14.7%12.8%15.0%16.2%12.7%12.0%13.8%14.0%
Cash & Debt            
Total Cash6,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,919
Total Debt35,22934,18931,27535,31335,40535,60834,91735,28434,00835,25734,48829,160
Net Debt / (Cash)28,83928,24225,70528,66826,58228,35826,83729,13330,87531,77525,96426,241
Cash Flows Quarterly            
FCF from Operations1,3997233,2902,1661,9601,2513,7232,4141,5407293,4871,937
Cash Flows TTM            
FCF from Operations TTM7,5788,1398,6679,1009,3488,9288,4068,1707,6937,6819,1548,124
Returns to Shareholders Quarterly            
Dividends162149149150149135136135135117117118
Share Repurchases-02,0001,000-0-03,000-0-0-03,0001,000-0
Return on Invested Capital (ROIC) Quarterly            
ROIC25.1%24.2%32.2%24.8%26.5%19.6%26.6%25.9%22.0%20.4%26.6%26.1%
Return on Invested Capital (ROIC) TTM            
ROIC TTM25.6%25.9%27.2%23.4%25.7%23.8%26.0%23.8%21.9%21.6%29.8%31.7%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Laboratory Products and Biopharma Services23,04122,51114,86212,24510,599
Life Sciences Solutions9,97713,53215,63112,1686,856
Analytical Instruments7,2636,6246,0695,1245,522
Specialty Diagnostics4,4054,7635,6595,3433,718
Elimination of intersegment revenues-1,829-2,515-3,010-2,662-1,153
Total42,85744,91539,21132,21825,542


Operating Income by Segment
$ Mil20242023202220212020
Life Sciences Solutions3,4205,5827,8176,1092,446
Laboratory Products and Biopharma Services3,3582,8721,8441,2711,324
Analytical Instruments1,9081,5071,1978081,273
Specialty Diagnostics1,1241,0241,2801,368930
Selling, general and administrative expenses adjustments-59-37-14410-62
Cost of revenues adjustments-95-46-8-6-17
Restructuring and other costs-459-114-197-99413
Amortization of acquisition-related intangible assets-2,338-2,395-1,761-1,667-1,713
Total6,8598,39310,0287,7944,594


Assets by Segment
$ Mil20242023202220212020
Unallocated amounts85,31483,340   
Laboratory Products and Biopharma Services6,3506,42852,63922,71121,761
Life Sciences Solutions3,1863,84522,75120,20918,306
Analytical Instruments2,7262,4659,6929,7739,896
Specialty Diagnostics1,1501,0766,0106,5345,867
Corporate/Other  4,0319,8252,551
Total98,72697,15495,12369,05258,381


Price Behavior

TMO Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta0.831.351.230.940.840.87
Up Beta1.541.651.080.920.860.97
Down Beta0.650.662.051.040.920.88
Up Capture87%193%142%68%44%38%
Bmk +ve Days10223571142415
Stock +ve Days12223760115372
Down Capture19%70%60%100%94%98%
Bmk -ve Days11192754106334
Stock -ve Days9192565133378

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity3,944,909
Short Interest: % Change Since 81520253.2%
Average Daily Volume1,659,725
Days-to-Cover Short Interest2.38
Basic Shares Quantity378,000,000
Short % of Basic Shares1.0%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/23/20259.1%12.8%15.7%
4/23/2025-0.7%-1.7%-8.4%
1/30/20256.8%2.5%-6.9%
10/23/2024-1.7%-6.6%-12.5%
7/24/20244.1%11.4%10.5%
4/24/20240.5%-1.0%2.8%
1/31/2024-5.0%-1.2%0.5%
10/25/2023-5.5%-2.9%6.4%
...
SUMMARY STATS   
# Positive151313
# Negative91111
Median Positive3.0%4.6%6.3%
Median Negative-2.8%-1.7%-6.9%
Max Positive9.1%12.8%15.7%
Max Negative-5.5%-6.6%-12.9%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025801202510-Q 6/28/2025
3312025502202510-Q 3/29/2025
12312024220202510-K 12/31/2024
93020241101202410-Q 9/30/2024
6302024802202410-Q 6/29/2024
3312024503202410-Q 3/30/2024
12312023222202410-K 12/31/2023
93020231103202310-Q 9/30/2023
6302023804202310-Q 7/1/2023
3312023505202310-Q 4/1/2023
12312022223202310-K 12/31/2022
93020221104202210-Q 10/1/2022
6302022805202210-Q 7/2/2022
3312022506202210-Q 4/2/2022
12312021224202210-K 12/31/2021
93020211104202110-Q 10/2/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Pettiti GianlucaExecutive Vice President7282025Sell479.98400191,99210,735,677Form
1Pettiti GianlucaExecutive Vice President5132025Sell411.11400164,4449,359,711Form
2Pettiti GianlucaExecutive Vice President4302025Sell429.93300128,9799,960,156Form
3Boxer Michael ASVP and General Counsel3112025Sell532.523,7752,010,5375,759,762Form
4Chai Nelson 2212025Buy555.89168,8947,929,215Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.